- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Congress of Clinical Rheumatology (CCR)
Zachary S Wallace, MD: What’s New in IgG4 Disease?
May 19, 2022
Zachary S Wallace, MD, explains his approach to diagnosing and managing IgG4-related disease and some of the clinical trials that are on the horizon.
Janet Pope, MD, MPH: Treating Unresponsive Rheumatoid Arthritis
May 18, 2022
Janet Pope, MD, MPH, explains her treatment strategies for unresponsive patients with rheumatoid arthritis as well as clinical pearls of 2021.
Julie J Paik, MD, MHS: Inflammatory Myopathy in Systemic Rheumatic Diseases
May 18, 2022
Julie J Paik, MD, MHS, discusses the clinicoserological spectrum of inflammatory myopathy in the context of rheumatic diseases and how autoantibody profiles can help predict myositis phenotype and disease course.
Leonard Calabrese, DO: Immunology for the Rheumatologist
May 16, 2022
Leonard Calabrese, DO, explains the history of interferon history in rheumatology, immunology for the rheumatologist, and COVID-19 immunology regarding autoimmune and inflammatory manifestations.
Arthur Kavanaugh, MD: Hot Topics in Rheumatoid Arthritis and Psoriatic Arthritis
May 16, 2022
Arthur Kavanaugh, MD, discusses his recent CCR East presentations “The Immunopathogenesis of Psoriatic Arthritis and Immunologically Targeted Therapy” and “Hot Topics in Rheumatoid Arthritis.”
Jason Kolfenbach, MD: Top Secrets in Rheumatology
September 20, 2021
Jason Kolfenbach, MD, discusses his CCR West presentations entitled “Common Eye Disorders in Rheumatology Clinic” and “Top Secrets in Rheumatology.”
John Cush, MD: Rheumatoid Arthritis Year in Review
August 12, 2021
John Cush, MD, discusses his upcoming lecture entitled, “Rheumatoid Arthritis: Year in Review,” which will be presented at the Congress of Clinical Rheumatology.
Randall Cron, MD, PhD: The Role of Rheumatologists in COVID-19
August 12, 2021
Randall Cron, MD, PhD, discuss his lectures entitled, “The Immunology of COVID” and “The Role of Rheumatologists in COVID-19,” which will be presented at the Congress of Clinical Rheumatology.
Research Update: Cytokine Storm Syndrome
September 28, 2020
Various drug therapies, including several cytokine blockers, are showing promise in addressing COVID-19 related cytokine storm syndrome, says Dr. Randall Cron of Children’s Hospital of Alabama.
Reassessing CVD Risk in Rheumatic Disease
September 23, 2020
Some drugs used to treat lupus and other connective tissue diseases have been shown to increase cardiovascular risks. Even so, those drugs remain effective in addressing disease symptoms, and a leading rheumatology researcher has suggested that concerns may not be fully warranted.